Magali Genevray
Overview
Explore the profile of Magali Genevray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Konopleva M, Rollig C, Cavenagh J, Deeren D, Girshova L, Krauter J, et al.
Blood Adv
. 2022 Apr;
6(14):4147-4156.
PMID: 35413116
The phase 3 MIRROS (MDM2 antagonist Idasanutlin in Relapsed or Refractory acute myeloid leukemia [AML] for Overall Survival) trial (NCT02545283) evaluated the efficacy and safety of the small-molecule MDM2 antagonist...
2.
Davies A, Merli F, Mihaljevic B, Mercadal S, Siritanaratkul N, Solal-Celigny P, et al.
Lancet Haematol
. 2017 May;
4(6):e272-e282.
PMID: 28476440
Background: Intravenous rituximab is the standard of care in B-cell non-Hodgkin lymphoma, and is administered over 1·5-6 h. A subcutaneous formulation could reduce patients' treatment burden and improve resource utilisation...
3.
Keller T, Cambon N, Genevray M, Crivelli F, Crivelli M, Dal B, et al.
Arzneimittelforschung
. 2005 Oct;
55(9):491-7.
PMID: 16229112
Fluoxetine hydrochloride (CAS 59333-67-4) is a selective serotonin reuptake inhibitor (SSRI) widely used as antidepressant drug. The aim of the present trial was to assess the bioequivalence of a new...